Vor Biopharma Inc (VOR)
1.69
-0.07
(-3.98%)
USD |
NASDAQ |
May 07, 15:12
Vor Biopharma Cash from Investing (Quarterly): 10.34M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 10.34M |
| September 30, 2023 | 40.54M |
| June 30, 2023 | 13.64M |
| March 31, 2023 | 6.498M |
| December 31, 2022 | -97.04M |
| September 30, 2022 | 12.70M |
| June 30, 2022 | -2.702M |
| March 31, 2022 | -7.055M |
| Date | Value |
|---|---|
| December 31, 2021 | -5.953M |
| September 30, 2021 | -8.486M |
| June 30, 2021 | -76.04M |
| March 31, 2021 | -1.171M |
| December 31, 2020 | -1.477M |
| September 30, 2020 | -1.587M |
| June 30, 2020 | -0.552M |
| March 31, 2020 | -0.545M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-97.04M
Minimum
Dec 2022
40.54M
Maximum
Sep 2023
-7.431M
Average
-1.324M
Median
Cash from Investing (Quarterly) Benchmarks
| Masimo Corp | -25.30M |
| AnaptysBio Inc | 49.18M |
| Apellis Pharmaceuticals Inc | 0.004M |
| NovaBay Pharmaceuticals Inc | -0.002M |
| Palatin Technologies Inc | 9.462M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -24.03M |
| Cash from Financing (Quarterly) | 0.025M |
| Free Cash Flow | -101.36M |
| Free Cash Flow Per Share (Quarterly) | -0.3558 |
| Free Cash Flow Yield | -89.27% |